Tracked deals
3
3 tracked deals across 2020-2026.
London, England, United Kingdom
H2 Equity Partners is a value-add private equity investment firm founded in 1991. It invests in mid-sized, profitable companies in the UK and Ireland and works with management to drive growth and operational improvement.
Tracked deals
3
3 tracked deals across 2020-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
1 addon · 1 buyout · 1 growth capital
Last 3 years
Supporting Data
H2 Equity Partners backed Metals and Additives, then combined it with William Blythe to create an international specialty chemicals platform. The merged platform focuses on regulated and mission-critical applications, with particular strengths in flame retardants and smoke suppressants across North America, Europe, and Asia.
H2 Equity Partners has made a multimillion-pound growth investment in Motive Offshore Group to support the company's international expansion and accelerate its shift into renewables. The deal adds two H2 representatives to Motive's executive board, replaces previous investor EV Private Equity and will fund continued M&A, fleet expansion and digitalisation of equipment and services.
H2 Equity Partners has exchanged contracts to acquire Optegra International Limited, a pan‑European ophthalmology group operating 23 eye hospitals across the United Kingdom, Czech Republic and Poland. Completion is subject to regulatory conditions and expected early 2021; H2 will partner with CEO Dr Peter Byloos and management to execute Optegra's growth strategy and expand its eye‑care services.
Turn tracked acquisition activity into an outreach-ready buyer list.